Skip to main content
Quest Diagnostics

Changes in Physical Function and Inflammatory Gut Microbiota in Survivors of Cancer

MASCC/ISOO 2025

Multinational Association of Supportive Care in Cancer / The International Agency for the Prevention of Blindness

Seattle, June 26- 2025

Oral presentation: Changes in Physical Function and Inflammatory Gut Microbiota in Survivors of Cancer

Authors: Hammer M, Brassil K

Medical Specialty: Oncology

Disclaimer: One or more of the authors of this publication were employed at the time by Pack Health, a subsidiary of Quest Diagnostics.

Related content

Conference Presentation
Correlating Patient Reported Outcomes Changes With Changes in Gut Microbiota in Cancer Survivors: COACH Study Trial in Progress
Conference Presentation
Comprehensive Outcomes for After Cancer Health (COACH) Study: 2024 Trial in Progress Updates
Conference Presentation
Comprehensive Outcomes for After Cancer Health (COACH) Study: 2024 Trial in Progress Updates
Conference Presentation
Comprehensive Outcomes for After Cancer Health: COACH
Audio Podcast
Optimize Oncology Care with Clinical Pathways

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2025 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.